172 related articles for article (PubMed ID: 38394781)
1. NCCN Guidelines® Insights: Kidney Cancer, Version 2.2024.
Motzer RJ; Jonasch E; Agarwal N; Alva A; Bagshaw H; Baine M; Beckermann K; Carlo MI; Choueiri TK; Costello BA; Derweesh IH; Desai A; Ged Y; George S; Gore JL; Gunn A; Haas N; Johnson M; Kapur P; King J; Kyriakopoulos C; Lam ET; Lara PN; Lau C; Lewis B; Madoff DC; Manley B; Michaelson MD; Mortazavi A; Ponsky L; Ramalingam S; Shuch B; Smith ZL; Sosman J; Sweis R; Zibelman M; Schonfeld R; Stein M; Gurski LA
J Natl Compr Canc Netw; 2024 Feb; 22(1):4-16. PubMed ID: 38394781
[TBL] [Abstract][Full Text] [Related]
2. NCCN Guidelines Insights: Kidney Cancer, Version 1.2021.
Motzer RJ; Jonasch E; Boyle S; Carlo MI; Manley B; Agarwal N; Alva A; Beckermann K; Choueiri TK; Costello BA; Derweesh IH; Desai A; George S; Gore JL; Haas N; Hancock SL; Kyriakopoulos C; Lam ET; Lau C; Lewis B; Madoff DC; McCreery B; Michaelson MD; Mortazavi A; Nandagopal L; Pierorazio PM; Plimack ER; Ponsky L; Ramalingam S; Shuch B; Smith ZL; Somer B; Sosman J; Dwyer MA; Motter AD
J Natl Compr Canc Netw; 2020 Sep; 18(9):1160-1170. PubMed ID: 32886895
[TBL] [Abstract][Full Text] [Related]
3. Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
Motzer RJ; Jonasch E; Agarwal N; Alva A; Baine M; Beckermann K; Carlo MI; Choueiri TK; Costello BA; Derweesh IH; Desai A; Ged Y; George S; Gore JL; Haas N; Hancock SL; Kapur P; Kyriakopoulos C; Lam ET; Lara PN; Lau C; Lewis B; Madoff DC; Manley B; Michaelson MD; Mortazavi A; Nandagopal L; Plimack ER; Ponsky L; Ramalingam S; Shuch B; Smith ZL; Sosman J; Dwyer MA; Gurski LA; Motter A
J Natl Compr Canc Netw; 2022 Jan; 20(1):71-90. PubMed ID: 34991070
[TBL] [Abstract][Full Text] [Related]
4. NCCN Guidelines Insights: Kidney Cancer, Version 2.2020.
Motzer RJ; Jonasch E; Michaelson MD; Nandagopal L; Gore JL; George S; Alva A; Haas N; Harrison MR; Plimack ER; Sosman J; Agarwal N; Bhayani S; Choueiri TK; Costello BA; Derweesh IH; Gallagher TH; Hancock SL; Kyriakopoulos C; LaGrange C; Lam ET; Lau C; Lewis B; Manley B; McCreery B; McDonald A; Mortazavi A; Pierorazio PM; Ponsky L; Redman BG; Somer B; Wile G; Dwyer MA; ; Hammond LJ; Zuccarino-Catania G
J Natl Compr Canc Netw; 2019 Nov; 17(11):1278-1285. PubMed ID: 31693980
[TBL] [Abstract][Full Text] [Related]
5. NCCN clinical practice guidelines in oncology: kidney cancer.
Motzer RJ; Agarwal N; Beard C; Bolger GB; Boston B; Carducci MA; Choueiri TK; Figlin RA; Fishman M; Hancock SL; Hudes GR; Jonasch E; Kessinger A; Kuzel TM; Lange PH; Levine EG; Margolin KA; Michaelson MD; Olencki T; Pili R; Redman BG; Robertson CN; Schwartz LH; Sheinfeld J; Wang J
J Natl Compr Canc Netw; 2009 Jun; 7(6):618-30. PubMed ID: 19555584
[No Abstract] [Full Text] [Related]
6. Therapeutic approaches in clear cell and non-clear cell renal cell carcinoma.
Vermassen T; De Meulenaere A; Van de Walle M; Rottey S
Acta Clin Belg; 2017 Feb; 72(1):12-18. PubMed ID: 27356035
[TBL] [Abstract][Full Text] [Related]
7. Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
Motzer RJ; Jonasch E; Agarwal N; Bhayani S; Bro WP; Chang SS; Choueiri TK; Costello BA; Derweesh IH; Fishman M; Gallagher TH; Gore JL; Hancock SL; Harrison MR; Kim W; Kyriakopoulos C; LaGrange C; Lam ET; Lau C; Michaelson MD; Olencki T; Pierorazio PM; Plimack ER; Redman BG; Shuch B; Somer B; Sonpavde G; Sosman J; Dwyer M; Kumar R
J Natl Compr Canc Netw; 2017 Jun; 15(6):804-834. PubMed ID: 28596261
[TBL] [Abstract][Full Text] [Related]
8. Kidney cancer, version 3.2015.
Motzer RJ; Jonasch E; Agarwal N; Beard C; Bhayani S; Bolger GB; Chang SS; Choueiri TK; Costello BA; Derweesh IH; Gupta S; Hancock SL; Kim JJ; Kuzel TM; Lam ET; Lau C; Levine EG; Lin DW; Michaelson MD; Olencki T; Pili R; Plimack ER; Rampersaud EN; Redman BG; Ryan CJ; Sheinfeld J; Shuch B; Sircar K; Somer B; Wilder RB; Dwyer M; Kumar R;
J Natl Compr Canc Netw; 2015 Feb; 13(2):151-9. PubMed ID: 25691606
[TBL] [Abstract][Full Text] [Related]
9. EAU guidelines on renal cell carcinoma: the 2010 update.
Ljungberg B; Cowan NC; Hanbury DC; Hora M; Kuczyk MA; Merseburger AS; Patard JJ; Mulders PF; Sinescu IC;
Eur Urol; 2010 Sep; 58(3):398-406. PubMed ID: 20633979
[TBL] [Abstract][Full Text] [Related]
10. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update.
Ljungberg B; Albiges L; Abu-Ghanem Y; Bensalah K; Dabestani S; Fernández-Pello S; Giles RH; Hofmann F; Hora M; Kuczyk MA; Kuusk T; Lam TB; Marconi L; Merseburger AS; Powles T; Staehler M; Tahbaz R; Volpe A; Bex A
Eur Urol; 2019 May; 75(5):799-810. PubMed ID: 30803729
[TBL] [Abstract][Full Text] [Related]
11. Consensus paper: current state of first- and second-line therapy in advanced clear-cell renal cell carcinoma.
Goebell PJ; Ivanyi P; Bedke J; Bergmann L; Berthold D; Boegemann M; Busch J; Doehn C; Krege S; Retz M; Amsberg GV; Grimm MO; Gruenwald V
Future Oncol; 2020 Oct; 16(29):2307-2328. PubMed ID: 32964728
[TBL] [Abstract][Full Text] [Related]
12. Advanced renal cell carcinoma (RCC) management: an expert panel recommendation from the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG).
Soares A; Monteiro FSM; Maluf FC; Bastos DA; Jardim DL; Sasse AD; Gonçalves E Silva A; Fay AP; da Rosa DAR; Wierman E; Kater F; Schutz FA; de Oliveira FNG; Morbeck IAP; Rinck JA; da Trindade KM; Maia MC; Souza VC; da Silva Neto DCV; de Almeida E Paula F; Korkes F; Carvalhal GF; Nogueira L; de Carvalho Fernandes R; Dos Reis RB; Matheus WE; Busato WFS; da Costa WH; de Cássio Zequi S
J Cancer Res Clin Oncol; 2020 Jul; 146(7):1829-1845. PubMed ID: 32410064
[TBL] [Abstract][Full Text] [Related]
13. [Renal cell carcinoma: what is new in 2010?].
Tsaur I; Haferkamp A
Urologe A; 2011 Sep; 50 Suppl 1():216-8. PubMed ID: 21837489
[TBL] [Abstract][Full Text] [Related]
14. [CCAFU Recommendations 2013: Renal cancer].
Patard JJ; Baumert H; Bensalah K; Bernhard JC; Bigot P; Escudier B; Grenier N; Hétet JF; Long JA; Méjean A; Paparel P; Richard S; Rioux-Leclercq N; Coloby P; Soulié M;
Prog Urol; 2013 Nov; 23 Suppl 2():S177-204. PubMed ID: 24485292
[TBL] [Abstract][Full Text] [Related]
15. Genitourinary imaging: part 2, role of imaging in medical management of advanced renal cell carcinoma.
Shinagare AB; Krajewski KM; Jagannathan JP; Ramaiya NH
AJR Am J Roentgenol; 2012 Nov; 199(5):W554-64. PubMed ID: 23096199
[TBL] [Abstract][Full Text] [Related]
16. NCCN Guidelines Updates: Management of Metastatic Kidney Cancer.
Jonasch E
J Natl Compr Canc Netw; 2019 May; 17(5.5):587-589. PubMed ID: 31117033
[TBL] [Abstract][Full Text] [Related]
17. Optimal Surveillance Strategies After Surgery for Renal Cell Carcinoma.
Tyson MD; Chang SS
J Natl Compr Canc Netw; 2017 Jun; 15(6):835-840. PubMed ID: 28596262
[TBL] [Abstract][Full Text] [Related]
18. [Clinical recommendations for treating and monitoring patients with renal cancer].
Petković M; Vrdoljak E; Ruzić IP; Belev B; Omrcen T; Ledina D; Tomek R; Ruzić B; Situm M; Buća A; Pisac VP;
Lijec Vjesn; 2012; 134(1-2):5-8. PubMed ID: 22519246
[TBL] [Abstract][Full Text] [Related]
19. Urological cancer: towards rational post-nephrectomy follow-up guidelines in RCC.
Patard JJ; Escudier B
Nat Rev Clin Oncol; 2015 Mar; 12(3):131-2. PubMed ID: 25668729
[No Abstract] [Full Text] [Related]
20. Diagnosis and Management of Hereditary Renal Cell Cancer.
Menko FH; Maher ER
Recent Results Cancer Res; 2016; 205():85-104. PubMed ID: 27075350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
